Showing results (1831-1840 of 3,593) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|March 15, 2020
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysisMariana Alves Fonseca, Joanna Zhi Jie Ling, Omar Al-Siyabi, et al.Journal of Viral Hepatitis|February 28, 2020
Validation of hepatitis C virus RNA detection using capillary blood by finger prick (GenXpert system)-Hepatitis C fingerprick studyRob Bielen, Özgür M Koc, Dana Busschots, et al.Journal of Viral Hepatitis|October 14, 2020
Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, PakistanNyashadzaishe Mafirakureva, Aaron G Lim, Gul Ghuttai Khalid, et al.Journal of Viral Hepatitis|October 8, 2020
Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovirJin Won Chang, Jae Seung Lee, Hye Won Lee, et al.Journal of Viral Hepatitis|July 27, 2021
Estimating the transmissibility of hepatitis C: A modelling study in Yichang City, ChinaYao Wang, Zeyu Zhao, Hao Zhang, et al.Journal of Viral Hepatitis|July 5, 2022
Risk factors for hepatitis C virus infection at a large urban emergency departmentJames S Ford, Erika Hollywood, Bradley Steuble, et al.Journal of Viral Hepatitis|June 3, 2022
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agentsWei-Fan Hsu, Hsueh-Chou Lai, Po-Heng Chuang, et al.Journal of Viral Hepatitis|June 20, 2022
Impact of COVID-19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugsMichael W Traeger, Daniela K van Santen, Rachel Sacks-Davis, et al.Journal of Viral Hepatitis|January 9, 2021
Evaluation of seven rapid diagnostic tests for detection of hepatitis C virus antibodies in ChinaBing Chen, Zhong-Hui Ma, Bing Xu, et al.Journal of Viral Hepatitis|January 10, 2021
The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort studyYeqiong Zhang, Wenxiong Xu, Xiang Zhu, et al.Pageof 360